Luoxin Pharmaceuticals Group Stock Co., Ltd. (SHE:002793)

Market Cap	5.01B +10.8%
Revenue (ttm)	2.49B +3.0%
Net Income	-677.20M
EPS	-0.64
Shares Out	1.06B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	16,386,370
Average Volume	14,401,865
Open	4.880
Previous Close	4.720
Day's Range	4.690 - 4.910
52-Week Range	3.280 - 6.740
Beta	0.52
RSI	39.91
Earnings Date	Mar 9, 2026

About SHE:002793

Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, manufacture, and trading of drugs in China. The company provides antiviral, anti-infective, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers health care services. Luoxin Pharmaceuticals Group Stock Co., Ltd. was formerly known as Zhejiang Doyin Pump Industry Co., Ltd. and chan...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 3,196
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002793

Financial Performance

In 2024, SHE:002793's revenue was 2.65 billion, an increase of 11.99% compared to the previous year's 2.36 billion. Losses were -965.50 million, 46.0% more than in 2023.